WebJul 12, 2024 · VANCOUVER, BC, July 12, 2024 /PRNewswire/ — Incisive Genetics Inc. (“IG”), a privately held biotech company specializing in the research and development of a novel non-viral delivery platform for targeted CRISPR-based gene therapies, announced the close of its $2.5 million seed financing. WebIncisive Genetics is developing a delivery platform for genetic therapies. This disruptive and transformational lipid nanoparticle (LNP) based delivery platform generated using IG’s …
Incisive Genetics Announces The Appointment Of Dr. Kevin Chow …
WebSep 22, 2024 · The company is building a transformational lipid nanoparticle-based gene-editing platform created for a one-step encapsulation of key active components in one … WebIndustries Biotechnology Genetics Health Care Medical Device Founded Date 2024 Founders Austin Hill, Blair Leavitt, Pamela Wagner Operating Status Active Last Funding Type Seed … dwrutil
Exocure VentureRadar
WebJul 14, 2024 · Incisive Genetics Inc., a privately held biotech company specializing in the research and development of a novel non-viral delivery platform for targeted CRISPR … WebOur Technology. Our Incisive Delivery System™ (patent-pending) is a proprietary, non-viral delivery method for CRISPR-based gene therapies. It was developed to address the need in the gene therapy space for a true platform delivery technology. We are developing therapeutics comprised of our proprietary delivery platform, active CRISPR ... WebIncisive Genetics Inc. (IG) is a Canadian biotech firm that is focused on developing its innovative lipid nanoparticle (LNP) delivery platform for genetic therapies. We believe the proprietary Incisive Delivery System™ provides a solution to the... http://www.incisivegenetics.com/ Myosana Therapeutics Private Company Founded 2024 … crystallization in breast